Scientists at work 35 The biotechnologist – Difinigen clone liver cells for pharmacology

We talk to Dr Marcus Yeo about how human cell production benefits drug development. Dr Yeo is from DifiniGEN, a Cambridge company that grows liver cells used to test if new drugs are harmful. Their technology comes from the Nobel Prize-winning work of Cambridge university’s Sir John Gurdon. The ability to grow special cells from stem cells also offers the possibility for organ replacement in the future.

Follow-up link:

  • DifiniGEN definigen.com

18/02/2013 Tagged 105science, biology, Chris Creese, DNA, health, Roger Frost

This entry was posted in podcasts, Science interview and tagged , . Bookmark the permalink.